Cochlear Ltd (OC5) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB −0,50%	1 098,58	−5,52	−0,50%	—	1 104,10	1 103,92	1 108,75	1 097,16	—	—
SIXC Communications SIXC Communications	SIXC +0,61%	607,82	+3,71	+0,61%	—	604,16	604,16	610,19	604,12	—	—
SIXE Energy SIXE Energy	SIXE −0,12%	1 196,41	−1,40	−0,12%	—	1 197,81	1 200,58	1 213,07	1 196,92	—	—
SIXI Industrials SIXI Industrials	SIXI −0,21%	1 736,81	−3,60	−0,21%	—	1 740,41	1 739,55	1 750,27	1 730,60	—	—
SIXM Financials SIXM Financials	SIXM +0,61%	638,28	+3,84	+0,61%	—	634,44	633,13	639,67	633,01	—	—
SIXR Staples SIXR Staples	SIXR −0,53%	836,46	−4,44	−0,53%	—	840,90	839,53	841,73	835,32	—	—
SIXRE Real estate SIXRE Real estate	SIXRE −0,44%	214,19	−0,94	−0,44%	—	215,13	215,13	215,85	213,99	—	—
SIXT Technology SIXT Technology	SIXT −0,38%	3 216,59	−12,12	−0,38%	—	3 228,71	3 225,62	3 227,74	3 198,95	—	—
SIXU Utilities SIXU Utilities	SIXU +0,16%	937,39	+1,52	+0,16%	—	935,87	938,37	942,00	937,00	—	—
SIXV Health care SIXV Health care	SIXV −0,03%	1 456,65	−0,47	−0,03%	—	1 457,12	1 452,74	1 466,88	1 449,55	—	—
SIXY Discretionary SIXY Discretionary	SIXY −0,99%	2 376,07	−23,77	−0,99%	—	2 399,84	2 389,71	2 392,30	2 371,22	—	—

OC5:FRA

Cochlear Ltd

58,04 €

−3,27%

(−1,96) 1 D

27. apr., 08:07:04 GMT+2 · EUR

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for OC5 …

Åpne

58,04 €

Høy

58,04 €

Lav

58,04 €

Markedsverdi

6,23 mrd.

Snittvolum

27,00

Volum

0,00

52 u høy

179,94 €

52 u lav

58,04 €

Antall ansatte

Nyhetssaker

Fra kilder på nettet

The Motley Fool Australia

for 2 døgn siden

After falling 43% in a week, are Cochlear shares now a buy?

The Motley Fool Australia

for 2 døgn siden

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Profil

Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant. Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015. Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia

Om Cochlear Ltd

Administrerende direktørDig Howitt

Ansatte5,5k

Grunnlagt1981

HovedkontorSydney, New South Wales, Australia

Sektor-

Nettstedcochlear.com

Alle verdier i AUD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	585,65 mill.	585,65 mill.	583,60 mill.	583,60 mill.
Varekostnad	158,85 mill.	158,85 mill.	159,60 mill.	159,60 mill.
Direkte driftskostnader	158,85 mill.	158,85 mill.	159,60 mill.	159,60 mill.
Utgifter til forskning og utvikling	73,55 mill.	73,55 mill.	76,40 mill.	76,40 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	234,95 mill.	234,95 mill.	224,70 mill.	224,70 mill.
Driftskostnader	301,25 mill.	301,25 mill.	297,85 mill.	297,85 mill.
Totale driftskostnader	460,10 mill.	460,10 mill.	457,45 mill.	457,45 mill.
Driftsinntekter	125,55 mill.	125,55 mill.	126,15 mill.	126,15 mill.
Andre ikke-operasjonelle inntekter	-	-	-	-
EBT inkludert uvanlige elementer	121,10 mill.	121,10 mill.	106,55 mill.	106,55 mill.
EBT uten uvanlige elementer	122,40 mill.	122,40 mill.	128,25 mill.	128,25 mill.
Kostnad for inntektsskatt	29,20 mill.	29,20 mill.	25,80 mill.	25,80 mill.
Faktisk avgiftssats	24,11 %	24,11 %	24,21 %	24,21 %
Andre driftskostnader	−7,25 mill.	−7,25 mill.	−3,25 mill.	−3,25 mill.
Nettoinntekt	91,90 mill.	91,90 mill.	80,75 mill.	80,75 mill.
Netto fortjenestemargin	15,69 %	15,69 %	13,84 %	13,84 %
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	2,15 mill.	2,15 mill.	4,20 mill.	4,20 mill.
Rentekostnader	−2,65 mill.	−2,65 mill.	−3,15 mill.	−3,15 mill.
Netto rentekostnader	−500,00k	−500,00k	1,05 mill.	1,05 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	129,05 mill.	129,05 mill.	151,95 mill.	151,95 mill.
Gevinst eller tap ved salg av eiendeler	−50,00k	−50,00k	-	-

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning